This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
BACKGROUND: We hypothesized that the lack of benefit of setting a low versus a high PEEP in patients with ARDS may be due in part to differences in the dynamic behavior of the expiratory valve in ventilators. We tested this hypothesis by conducting a bench comparison of the dynamic behavior of expiratory valves on ICU ventilators currently in use.
METHODS: We attached 7 ICU ventilators (C5, C6, Carescape, PB980, ServoU, V500, and V680) to the ASL 5000 lung model (passive condition with compliance 20 mL/cm H2O and resistance 5 cm H2O/L/s) and set in volume controlled mode (tidal volume 0.8 L, breathing frequency 10 breaths/min). Flow and pressure were measured just before the exhalation valve. At PEEP of 5, 10, and 15 cm H2O, the median instantaneous expiratory resistance, the time to valve opening, and the pressure time products above or below the values of PEEP (expressed in cm H2O × s) were determined.
RESULTS: Median instantaneous expiratory resistance values differed between the ventilators and PEEP settings with a significant interaction: at PEEP 5 cm H2O, the median (interquartile range) expiratory resistance values were 3.9 (3.5–4.7), 3.0 (3.0–3.1), 20.9 (15.8–24.9), 27.4 (26.5–43.2), 13.8 (13.6–13.9), 4.4 (4.0–4.6), and 34.3 (33.7–33.8) cm H2O/L/s, for the C5, C6, Carescape, PB980, ServoU, V500, and V680, respectively. For all the PEEP settings, the corresponding times to valve opening were 0.080 (0.077–0.082), 0.082 (0.080–0.085), 0.110 (0.105–0.110), 0.100 (0.085–1.05), 0.072 (0.062–0.072), 0.145 (0.115–0.150), and 0.075 (0.070–0.080) s, respectively, and pressure-time products were 2.8 (2.1–7.4), 6.8 (6.7–7.3), 2.4 (2.1–2.4), 3.5 (2.7–3.6), 1.8 (1.8–2.1), 2.8 (2.7–2.9), and 5.7 (5.4–5.9) cm H2O × s, respectively.
CONCLUSIONS: The resistance of active expiratory valves differed significantly between the 7 ICU ventilators tested.
Footnotes
- Correspondence: Claude Guérin MD PhD, Médecine Intensive-Réanimation, Groupement Hospitalier Centre, Hôpital Edouard Herriot, 5 place d’Arsonval, 69003 Lyon, France. E-mail: claude.guerin{at}chu-lyon.fr
The authors have disclosed no conflicts of interest.
- Copyright © 2021 by Daedalus Enterprises
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.